138423-98-0Relevant articles and documents
AMIDES OF ANTHRACYCLINE ANTIBIOTICS AND N-CARBOXYMETHYLASCORBIGEN
Korolev, A. M.,Lazhko, E. I.,Preobrazhenskaya, M. N.,Bal'zarini, Ya.,Klerk, E. De
, p. 805 - 808 (1991)
-
New nucleotide-competitive non-nucleoside inhibitors of terminal deoxynucleotidyl transferase: Discovery, characterization, and crystal structure in complex with the target
Costi, Roberta,Cuzzucoli Crucitti, Giuliana,Pescatori, Luca,Messore, Antonella,Scipione, Luigi,Tortorella, Silvano,Amoroso, Alessandra,Crespan, Emmanuele,Campiglia, Pietro,Maresca, Bruno,Porta, Amalia,Granata, Ilaria,Novellino, Ettore,Gouge, Jéro?me,Delarue, Marc,Maga, Giovanni,Di Santo, Roberto
, p. 7431 - 7441 (2013/10/21)
Terminal deoxynucletidyl transferase (TdT) is overexpressed in some cancer types, where it might compete with pol μ during the mutagenic repair of double strand breaks (DSBs) through the nonhomologous end joining (NHEJ) pathway. Here we report the discove
PHAMACEUTICAL PREPARATIONS COMPRISING INSULIN
-
Page/Page column 225, (2010/02/15)
Novel preparations comprising ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer wherein the ligand is extended by protamine that are capable of prolonging the ac-tion of insulin preparations.